Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma
Authors:
Wattenberg MM, Colby S, Garrido-Laguna I, [...]one or more additional authors omittedWang-Gillam A, [...]one or more additional authors omitted Beatty GL
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy
Authors:
Grierson PM, Suresh R, Tan B, [...]one or more additional authors omittedWang-Gillam A, Lim KH
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and met…
Authors:
Leidner R, Conlon K, McNeel DG, Wang-Gillam A, [...]one or more additional authors omitted Thompson JA
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
Authors:
Beatty GL, Delman D, Yu J, [...]one or more additional authors omittedWang-Gillam A, [...]one or more additional authors omitted Garrido-Laguna I
